English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Abbvie
Press release submission
| Jul 24, 2021
DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
Press release submission
| Aug 15, 2020
ABBVIE: New England Journal of Medicine Publishes Positive Phase 3 Data of Venetoclax Combination in Acute Myeloid Leukemia (AML) Patients
Press release submission
| Nov 26, 2018
ABBVIE: Receives US FDA Accelerated Approval for VENCLEXTA® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
Press release submission
| Sep 23, 2018
ABBVIE: Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
Carrie Bradon
| Nov 28, 2017
AbbVie to take part in Evercore ISI Biopharma Catalyst conference
Kathy Adams
| Nov 15, 2017
AbbVie executive to present at Jefferies London Healthcare Conference
Robert Hadley
| Nov 7, 2017
FDA fast-tracking review for AbbVie’s endometriosis drug
Mark Iandolo
| Nov 1, 2017
AbbVie to present abstracts on its investigational immunology medicine portfolio
Trending
+
Pharmaceuticals
Patient Daily
| Oct 22, 2024
Bristol Myers Squibb funds $2.25M cervical cancer project in Malawi
+
Pharmaceuticals
Patient Daily
| Oct 21, 2024
Baylor professors Bottazzi and Davis elected to National Academy of Medicine
+
Pharmaceuticals
Patient Daily
| Oct 22, 2024
American Lung Association welcomes three leaders to Georgia board
+
Pharmaceuticals
Patient Daily
| Oct 24, 2024
Dr. Huda Zoghbi honored by American Academy for her contributions to science
1
2
3
4
»
Last »
